Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tenon Medical, Inc.TNON · Entity 2063 | Director | July 31, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tenon Medical, Inc.
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,876 |
Reported balance
After 2026-07-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-31 · Exercise / conversion · Acquired 10,147 · Balance 20,876 F1: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-31 · Exercise / conversion · Disposed 10,147 · Balance 0 F1: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. F2: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 4, 2026 20:52 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 10,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-085248 · ownership.xml · derivative · entry 2 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. F1 · derivative.expiration_date: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:52 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 10,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-085248 · ownership.xml · nonDerivative · entry 1 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. Read SEC document |
| January 01, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 583 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001469 · ownership.xml · derivative · entry 4 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492 Underlying: Common Stock · 583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents conversion of 583 RSUs granted to the reporting person on May 8, 2024 into 583 shares of common stock of the Issuer on January 1, 2026. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026. F1 · derivative.expiration_date: Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026. Read SEC document |
| January 01, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 10,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001469 · ownership.xml · derivative · entry 3 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,147 Underlying: Common Stock · 10,146 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026. F1 · derivative.expiration_date: Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026. Read SEC document |
| January 01, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 583 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001469 · ownership.xml · nonDerivative · entry 2 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents conversion of 583 RSUs granted to the reporting person on May 8, 2024 into 583 shares of common stock of the Issuer on January 1, 2026. Read SEC document |
| January 01, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 10,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001469 · ownership.xml · nonDerivative · entry 1 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 21:09 UTC | Tenon Medical, Inc. TNON · Entity 2063 | GrantRestricted Stock Units · Derivative | 20,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-099211 · ownership.xml · derivative · entry 1 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,293 Underlying: Common Stock · 20,293 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026. F2 · derivative.expiration_date: Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026. Read SEC document |
| May 08, 2024 Filed Dec 22, 2025 17:40 UTC | Tenon Medical, Inc. TNON · Entity 2063 | GrantRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-124322 · ownership.xml · derivative · entry 1 Jacques Kristine M · CIK 0002017818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F1 · security: Represents a grant of 1,750 (as adjusted for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024) restricted stock units ("RSUs") of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 583 RSUs on January 1, 2026; 583 RSUs on May 8, 2026, and 584 RSUs on May 8, 2027. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents a grant of 1,750 (as adjusted for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024) restricted stock units ("RSUs") of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 583 RSUs on January 1, 2026; 583 RSUs on May 8, 2026, and 584 RSUs on May 8, 2027. F3 · derivative.expiration_date: N/A Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.